Evidence map›Paper›PMID 37380891›Full record

ArticleNeuroradiology2023

Comparison of diffusion weighted imaging b0 with T2*-weighted gradient echo or susceptibility weighted imaging for intracranial hemorrhage detection after reperfusion therapy for ischemic stroke.

Sven P R Luijten, Nadinda A M van der Ende, Sandra A P Cornelissen, Leo Kluijtmans, Antonius van Hattem, Geert Lycklama A Nijeholt, Alida A Postma, Reinoud P H Bokkers, Lars Thomassen, Ulrike Waje-Andreassen and 6 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Neuroradiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Sven P R LuijtenDepartment of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. s.luijten@erasmusmc.nl.ORCID http://orcid.org/0000-0002-6905-3296
Nadinda A M van der EndeDepartment of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-4681-8388
Sandra A P CornelissenDepartment of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0332-2158
Leo KluijtmansDepartment of Radiology, Isala Hospital, Zwolle, The Netherlands.ORCID http://orcid.org/0000-0002-1999-3378
Antonius van HattemDepartment of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Geert Lycklama A NijeholtDepartment of Radiology, Haaglanden Medisch Centrum, Hague, The Netherlands.ORCID http://orcid.org/0000-0001-6575-9868
Alida A PostmaDepartment of Radiology, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0002-1116-054X
Reinoud P H BokkersDepartment of Radiology, Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0001-6130-7311
Lars ThomassenDepartment of Neurology, Haukeland University Hospital, Bergen, Norway.ORCID http://orcid.org/0000-0002-6532-2591
Ulrike Waje-AndreassenDepartment of Neurology, Haukeland University Hospital, Bergen, Norway.ORCID http://orcid.org/0000-0003-3240-6040
Nicola LogalloDepartment of Neurosurgery, Haukeland University Hospital, Bergen, Norway.ORCID http://orcid.org/0000-0002-5453-293X
Serge BracardDepartment of Diagnostic and Interventional Neuroradiology, University Hospital of Nancy, Nancy, France.ORCID http://orcid.org/0000-0001-9423-6660
Benjamin GoryDepartment of Diagnostic and Interventional Neuroradiology, University Hospital of Nancy, Nancy, France.ORCID http://orcid.org/0000-0003-1186-3656
Bob RoozenbeekDepartment of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-8320-8303
Diederik W J DippelDepartment of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-9234-3515
Aad van der LugtDepartment of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-6159-2228
Erasmus MC · NLHaukeland University Hospital · NOCentre Hospitalier Régional et Universitaire de Nancy · FRIsala · NLMaastricht University · NLMedisch Centrum Haaglanden · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDiffusion-weighted imaging (DWI) b0 may be able to substitute T2*-weighted gradient echo (GRE) or susceptibility-weighted imaging (SWI) in case of comparable detection of intracranial hemorrhage (ICH), thereby reducing MRI examination time. We evaluated the diagnostic accuracy of DWI b0 compared to T2*GRE or SWI for detection of ICH after reperfusion therapy for ischemic stroke.

methodsWe pooled 300 follow-up MRI scans acquired within 1 week after reperfusion therapy. Six neuroradiologists each rated DWI images (b0 and b1000; b0 as index test) of 100 patients and, after a minimum of 4 weeks, T2*GRE or SWI images (reference standard) paired with DWI images of the same patients. Readers assessed the presence of ICH (yes/no) and type of ICH according to the Heidelberg Bleeding Classification. We determined the sensitivity and specificity of DWI b0 for detection of any ICH, and the sensitivity for detection of hemorrhagic infarction (HI1 & HI2) and parenchymal hematoma (PH1 & PH2).

resultsWe analyzed 277 scans of ischemic stroke patients with complete image series and sufficient image quality (median age 65 years [interquartile range, 54-75], 158 [57%] men). For detection of any ICH on DWI b0, the sensitivity was 62% (95% CI: 50-76) and specificity 96% (95% CI: 93-99). The sensitivity of DWI b0 was 52% (95% CI: 28-68) for detection of hemorrhagic infarction and 84% (95% CI: 70-92) for parenchymal hematoma.

conclusionDWI b0 is inferior for detection of ICH compared to T2*GRE/SWI, especially for smaller and more subtle hemorrhages. Follow-up MRI protocols should include T2*GRE/SWI for detection of ICH after reperfusion therapy.

Indexed as

Diffusion Magnetic Resonance ImagingIntracranial HemorrhagesIschemic StrokeAgedFemaleHumansMaleMiddle AgedReperfusionSensitivity and SpecificityIntracranial hemorrhageIschemic strokeMRIReperfusion

Identifiers

PMID37380891
PMCPMC10567825
OpenAlexW4382501337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.